CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a point-of-care testing device to differentiate between psoriasis and eczema using molecular signatures. It aims to improve diagnostic accuracy and treatment efficacy for inflammatory skin diseases, addressing a significant gap in current medical practices.
Innovative and effective biological therapies exist to treat non-communicable inflammatory skin diseases (ncISD).
However, diagnostic guidance when and how to use them is imprecise; no substantial innovation was made for decades.
Due to this lack of innovation, high socio-economic costs are caused by ineffective unguided treatment – a waste of resources.
Existing ERC research aims at establishing individualised medicine in ncISD (IMCIS, grant agreement 676858).
First success is a biomarker to di…
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
